Free tool
FAERS Monitor: Inderal La
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018553 or its brand name (Inderal La, Propranolol Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
20,561
Serious
14,089
69% of reports
Hospitalization
6,219
Death reported
2,107
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use2,090
- drug ineffective1,819
- nausea1,590
- fatigue1,370
- headache1,334
- diarrhoea1,061
- dyspnoea1,018
- dizziness1,016
- product use in unapproved indication956
- product use issue922
- pain870
- vomiting856
- fall793
- toxicity to various agents758
- asthenia745
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 466 |
| 2005 | 575 |
| 2006 | 536 |
| 2007 | 447 |
| 2008 | 381 |
| 2009 | 530 |
| 2010 | 642 |
| 2011 | 623 |
| 2012 | 730 |
| 2013 | 577 |
| 2014 | 601 |
| 2015 | 833 |
| 2016 | 886 |
| 2017 | 741 |
| 2018 | 865 |
| 2019 | 936 |
| 2020 | 917 |
| 2021 | 1,165 |
| 2022 | 1,575 |
| 2023 | 1,731 |
| 2024 | 2,098 |
| 2025 | 1,483 |
| 2026 | 1,222 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,598 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product use issueSignal | 922 | 5.0 | 4.7 | 2,992 |
| toxicity to various agentsSignal | 758 | 4.6 | 4.3 | 2,150 |
| product use in unapproved indicationSignal | 956 | 4.0 | 3.7 | 2,127 |
| off label useSignal | 2,090 | 2.4 | 2.3 | 1,857 |
| fallSignal | 793 | 2.4 | 2.3 | 682 |
| headacheSignal | 1,334 | 2.2 | 2.1 | 874 |
| dizzinessSignal | 1,016 | 2.1 | 2.0 | 586 |
| nauseaSignal | 1,590 | 2.1 | 2.0 | 895 |
| astheniaSignal | 745 | 2.0 | 1.9 | 394 |
| vomiting | 856 | 1.9 | 1.7 | 349 |
| dyspnoea | 1,018 | 1.8 | 1.7 | 400 |
| fatigue | 1,370 | 1.8 | 1.7 | 506 |
| diarrhoea | 1,061 | 1.7 | 1.6 | 302 |
| pain | 870 | 1.4 | 1.4 | 124 |
| drug ineffective | 1,819 | 1.4 | 1.4 | 233 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.